openPR Logo
Press release

Growing Advancement in Cancer Therapies to Provide Better Treatment to Propel Cancer Immunotherapy Market Growth at CAGR 8.4% by 2031

10-18-2024 12:18 AM CET | Associations & Organizations

Press release from: ABNewswire

Cancer Immunotherapy Market

Cancer Immunotherapy Market

Cancer Immunotherapy Market size was valued at USD 125.4 billion in 2022 and is poised to grow from USD 135.93 billion in 2023 to USD 259.16 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2024-2031).
[https://www.skyquestt.com/report/cancer-immunotherapy-market] size was valued at USD 135.93 billion in 2023 to USD 259.16 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2024-2031).Cancer immunotherapy is a kind of treatment that could enhance the immune systems' potential to fight against cancer. This treatment is more effective compared to the traditional method. This is because it provides long-term protection against cancer, can treat various types of cancer, and has less side effects. Cancers that can be treated with the help of immunotherapy consists of breast cancer, colorectal cancer, and prostate cancer. The demand for cancer immunotherapy is rapidly increasing because of the rising prevalence of cancer globally. Nowadays, people are also becoming more aware about the advantages of cancer immunotherapy, boosting the growth of the market. The popularity of immunotherapy is increasing among patients and medical providers as it offers targeted and personalized treatment option. Furthermore, continuous research and development on monoclonal antibodies, is also fueling advancement in the field and increasing treatment options. This is because these are the primary element of cancer biologics and immunotherapy treatments. These factors are developing a favourable market setting for cancer immunotherapy and boosting innovation in cancer treatment.

Request your free sample PDF of the report today: https://www.skyquestt.com/sample-request/cancer-immunotherapy-market

Emergence of Oncolytic Virus Treatment to Increase Demand for Cancer Immunotherapy

The oncolytic virus treatment is a type of immunotherapy. The viruses make use of genetically modified viruses that has the potential to infect and kill cancer cells, while leaving the healthy cells. The popularity of oncolytic virus therapy has increased especially after FDA gave its approval of the first oncolytic virus treatment for melanoma. Researchers are now emphasizing on engineering viruses that can provide therapeutic genes directly into the cancer cells and trigger an immune response against the tumor. The process of oncolytic virus treatment is directly destroying the tumor cells and helping the main immune system to target cancer more efficiently.

Developments in Checkpoint Inhibitors to Offer Advanced Therapeutic Options for Various Cancers

The checkpoint inhibitors have massively transformed the field of cancer treatment, offering new therapeutic choices for a wide range of cancers. These drugs function by blocking protein interactions that prevent T-cells, which is a kind of immune cells, from attacking cancer cells. Many companies are investing in the research of these checkpoint inhibitors due to the success of the drug targeting PD-1/PD-L1 and CTLA-4 pathways. Medical researchers are developing new advanced inhibitors that has the capability to target other immune checkpoints. The research and development of this drug is shifting towards combination therapies. In these types of treatment checkpoint inhibitors are utilized along with other kinds of cancer treatment to increase efficiency and overcome resistance.

In October 2023, Pfizer introduced new the MEKTOVI + BRAFTOVI treatment in the market. This treatment that can be used on adult patients suffering from metastatic non-small cell lung cancer.

In October 2023, the US FDA granted approval of Merck's anti-PD-1 therapy KEYTRUDA. This treatment can be used on patients with resectable non-small cell lung cancer (NSCLC).

In December 2023, the U.S. FDA provided approval for the FRUZAQLA for Previously Treated Metastatic Colorectal Cancer by Takeda

For a tailored report, contact us to request a free customization: https://www.skyquestt.com/speak-with-analyst/cancer-immunotherapy-market

Market has the Following Segments:

Type

Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies], Vaccines [Prophylactic Vaccines, Therapeutic Vaccines], Checkpoint Inhibitors [Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4), Programmed Death 1 (PD-1) & Programmed Death Ligand 1 (PD-L1)], Cell Therapies [Chimeric Antigen Receptor (CAR) T Cell Therapy, Dendritic Cells], Immunomodulators [Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf & G-Csf), Interferons (IFN), Interleukins (IL), Oncolytic Virus (Immunotherapy, Immunity as an Obstacle, Immunity as an Ally, Approved Products & Clinical Trails)]

Application

Lung Cancer Breast Cancer Multiple Myeloma Colorectal Cancer Head & Neck Cancer Prostate Cancer Melanoma Other Cancer Types

End User

Hospitals

Clinics

Others

Key Players Operating in the Cancer Immunotherapy Market

Amgen Inc.

AstraZeneca

Bayer AG

Bristol-Myers Squibb

Eli Lilly and Company

Janssen Global Services, LLC

Merck & Co., Inc.

Novartis

Pfizer Inc.

F. Hoffmann-La Roche Ltd

Gilead Sciences, Inc.

GlaxoSmithKline plc

AbbVie Inc.

Regeneron Pharmaceuticals, Inc.

Adaptimmune Therapeutics plc

Incyte Corporation

Bluebird bio, Inc.

BioNTech SE

Immunocore Limited

CureVac N.V.

BeiGene, Ltd.

Zymeworks Inc.

Purchase now to gain valuable insights and stay informed: https://www.skyquestt.com/buy-now/cancer-immunotherapy-market

Growing Demand for CAR-T Cell Therapies to Treat Specific Types of Leukemia and Lymphoma

The demand for chimeric antigen receptor T-cell therapy is rapidly increasing in cancer immunotherapy due to its constant advancement. This method is comprised of genetically modifying a patients T-cells for detecting and attacking cancer cells. The popularity of CAR-T cell therapies is increasing because it can be used for successfully treating certain kinds of leukemia and lymphoma. Many companies are also heavily investing in CAR-T cell therapies so that researchers can expand their usage in other cancers like solid tumors. Furthermore, constant research and innovation is also enhancing the safety and effectiveness of these therapies, especially in controlling serious immune reactions.

To read the full report, please visit: https://www.skyquestt.com/report/cancer-immunotherapy-market

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=growing-advancement-in-cancer-therapies-to-provide-better-treatment-to-propel-cancer-immunotherapy-market-growth-at-cagr-84-by-2031]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/cancer-immunotherapy-market



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Advancement in Cancer Therapies to Provide Better Treatment to Propel Cancer Immunotherapy Market Growth at CAGR 8.4% by 2031 here

News-ID: 3699219 • Views:

More Releases from ABNewswire

Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repair Services to Support St. Louis Park Homeowners
Bedrock Restoration - Water Fire Mold Damage Service, Expands Water Damage Repai …
Water Fire Mold Damage Service, a trusted provider of property restoration, has announced expanded service offerings to meet the growing demand for professional water damage solutions in the region. Known for their reliable, customer-focused approach, the company continues to support both homeowners and businesses in recovering from unexpected property damage caused by water, fire, or mold. Responding to a Growing Need for Water Damage Restoration Property owners across Minnesota are increasingly seeking
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Injury Attorneys Representation in Port Jefferson Station
Winkler Kurtz LLP Expands Resources to Handle Increased Demand for Personal Inju …
For individuals searching for personal injury attorneys, the expansion of Winkler Kurtz LLP's team means greater accessibility and reduced wait times for consultations. The firm's deep roots in the Port Jefferson Station community allow them to understand local nuances, such as common accident hotspots and specific regional legal precedents. Port Jefferson Station has seen a notable rise in personal injury cases, driven by factors such as increased traffic congestion, construction activity,
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washing Prevents Long-Term Damage in Millsboro DE
Protecting Property Value: Hose Bros Inc Highlights How Professional Power Washi …
For residents searching for power washing near me, Hose Bros Inc offers accessible and reliable services tailored to the Millsboro community. Their local expertise ensures an understanding of regional challenges, such as the impact of salt air on coastal properties or the tendency for humidity to promote mold growth in shaded areas. This knowledge allows them to customize their approach, selecting appropriate pressure levels and cleaning agents for different surfaces. In
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Prices
Tampa Bay Home Remodeling Costs Guide [2025] Kitchen & Bathroom Renovation Price …
A 2025 cost guide to kitchen, bathroom, and full home remodeling in Tampa Bay, featuring expert insights from Craftline Remodeling on pricing, budgeting, and contractor selection. Market Overview: Understanding Tampa Bay Remodeling Investment Trends Tampa Bay's home remodeling market has experienced significant cost evolution in 2025, with project expenses varying dramatically across South Tampa, Carrollwood, Seminole Heights, Clearwater, St. Petersburg, and Wesley Chapel based on material choices, project scope, and contractor expertise.

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For